medigraphic.com
Instituto Nacional de Salud Pública

2016, Number 2

<< Back Next >>

salud publica mex 2016; 58 (2)

The burden of cancer in Mexico, 1990-2013

Gómez-Dantés H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman-Retana O, Montero P, González-Robledo MC, Fitzmaurice C, Pain A, Allen C, Dicker DJ, Hamavid H, López A, Murray C, Naghavi M, Lozano R

Language: English
References: 61
Page: 118-131
PDF size: 704.38 Kb.


ABSTRACT

Objective. To analyze mortality and incidence for 28 cancers by deprivation status, age and sex from 1990 to 2013. Materials and methods. The data and methodological approaches provided by the Global Burden of Disease (GBD 2013) were used. Results. Trends from 1990 to 2013 show important changes in cancer epidemiology in Mexico. While some cancers show a decreasing trend in incidence and mortality (lung, cervical) others emerge as relevant health priorities (prostate, breast, stomach, colorectal and liver cancer). Age standardized incidence and mortality rates for all cancers are higher in the northern states while the central states show a decreasing trend in the mortality rate. The analysis show that infection related cancers like cervical or liver cancer play a bigger role in more deprived states and that cancers with risk factors related to lifestyle like colorectal cancer are more common in less marginalized states. Conclusions. The burden of cancer in Mexico shows complex regional patterns by age, sex, types of cancer and deprivation status. Creation of a national cancer registry is crucial.


REFERENCES

  1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385(9963):117-171.

  2. Anand P, Kunnumakara AB, Sundaram C, Harikumar K, Tharakan ST, Lai OS, et al. Cancer is a Preventable Disease that Requires Major Lifestyle Changes, Pharmaceutical Research, (# 2008) DOI: 10.1007/s11095-008-9661-9

  3. Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer 2013. JAMA Oncol 2015;1(4):505-527. doi:10.1001/jamaoncol. 2015.0735

  4. Bray F, Moller B. Predicting future burden of cancer. Nat Rev Cancer 2006;6:63-74.

  5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet 2013; 381(9867):628]. Lancet 2012;380(9859):2095-2128.

  6. Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010; 2: 376 (9747):1186-93. doi: 10.1016/ S0140-6736(10)61152-X

  7. Anderson B, Flanigan J. Novel Methods for Measuring Global Cancer Burden Implications for Global Cancer Control. JAMA Oncol 2015;1(4):425-427.

  8. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015; 385(9972):977-1010.

  9. Lim SS, Vos T, Flaxman AD, Danaei K, Shibuya G, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2224-2260.

  10. Tovar-Guzmán VJ, López-Antuñano FJ, Rodríguez-Salgado N. Tendencias de la mortalidad por cáncer pulmonar en México, 1980-2000. Rev Panam Salud Publica 2005;17(4):254-262.

  11. Murray Ch, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet 2012;380(9859):2063-2066.

  12. Murray Ch, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet 2012;380(9859):2197-2223.

  13. Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012;380(9859):2144-2162.

  14. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet 2012;380(9859):2163-2196.

  15. Wang H, Dwyer-Lindgren L, Lofgren KT, Knoll-Rajaratnam J, Marcus JR, Levin-Rector A. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2071-2094.

  16. Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray C. Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Population Health Metrics 2011; 9: 8.

  17. Supplement to GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and causespecific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; published online Dec 18. http://dx.doi.org/10.1016/S0140- 6736(14)61682-2.

  18. Ávila J L, Fuentes C, Tuirán R. Índices de Marginación 2000. México: CONAPO, 2001.

  19. CONAPO, Índice de marginación por entidad federativa y municipio 2010, Octubre 2011 [accessed december 2014]. Available at: http://www. conapo.gob.mx.

  20. Villalobos-Pérez JJ, Bourlon MT, Loaeza del Castillo A, Torres-Villalobos G. Variaciones en la frecuencia de cáncer del aparato digestivo en el transcurso de 35 años en cuatro instituciones de la Ciudad de México de distinto nivel socioeconómico. Gac Med Mex 2014;150:49-57.

  21. Lozano-Ascencio R, Gómez-Dantés H, Lewis S, Torres-Sánchez L, López-Carrillo L. Tendencias del cáncer de mama en América Latina y el Caribe. Salud Publica Mex 2009;51(S2):s147-s156.

  22. Tirado-Gómez L, Mohar-Betancourt A. Epidemiología del cáncer de colon y recto. Gaceta Sociedad Española de Oncología Médica 2008;7(S4):3-11.

  23. Méndez-Sánchez N, Villa A, Vázquez-Elizondo G, Ponciano-Rodríguez G, Uribe M. Mortality trends for liver cancer in Mexico from 2000 to 2006. Annals of Hepatology 2008;7(3):226-229.

  24. Tovar-Guzmán VJ, Ortiz-Contreras F, Jiménez-Gauna FR, Valencia-Vázquez G. Panorama epidemiológico de la mortalidad por cáncer cérvicouterino en México (1980-2004). Rev Fac Med UNAM 2008;51(2):47-51.

  25. Rizo-Ríos P, Sánchez-Cervantes F, González-Rivera A, Betancourt- Cravioto M, Meneses-García A, Mohar A, Kuri-Morales P. Mortalidad por leucemias en menores de 20 años. México 1998-2002. Bol Med Hosp Infant Mex 2005;62(1):9-18.

  26. Tovar-Guzmán V, Hernández-Girón C, Barquera S, Rodríguez-Salgado N, López-Carrillo L. Epidemiologic Panorama of Stomach Cancer Mortality in Mexico. Arch Med Res 2001;32:312-317.

  27. Abdullaev FI, Rivera-Luna R, Roitenburd-Belacortu V, Espinosa-Aguirre J. Pattern of Childhood Cancer Mortality in Mexico. Arch Med Res 2000;31:526-531.

  28. Torres-Sánchez LE, Rojas-Martínez R, Escamilla-Núñez C, de la Vara- Salazar E, Lazcano-Ponce E, Tendencias en la mortalidad por cáncer en México de 1980 a 2011. Salud Publica Mex 2014;56:473-491.

  29. Bosetti C, Rodríguez T, Chatenoud L, Bertuccio P, Levie F, Negri E, et al. Trends in cancer mortality in Mexico, 1981-2007. Eur J Cancer Prev 2011;20:355-363.

  30. Ortega-Cervantes L, Rojas-García AE, Robledo-Marenco ML, Barrón- Vivanco BS, Girón-Pérez MI, Vallejo-Ruiz V, et al. Morbidity of breast cancer and cervical-uterine cancer in women from the Occidental region of Mexico. Cancer morbidity in women. Rev Invest Clin 2013;65(3):221-227.

  31. Sánchez-Barriga J. Tendencias de mortalidad por cáncer cérvico-uterino en las siete regiones socioeconómicas y en las 32 entidades federativas de México en los años 2000-2008. Gac Med Mex 2012;148:42-51.

  32. El IMSS en cifras. Los tumores malignos en población derechohabiente, 1990-2003. Rev Med Inst Mex Seguro Soc 2005;43(4):349-356.

  33. Gómez-Villanueva A, Chacón-Sánchez J, Santillán-Arreygue L, Sánchez- González Y, Romero-Figueroa M. Incidencia de cáncer en una Unidad de Atención Oncológica del Instituto Mexicano del Seguro Social (IMSS), en Toluca, Estado de México. Gac Med Mex 2014;150:297-303.

  34. Gutiérrez-Trujillo G, Martínez-Montañez OG, Fernández-Gárate IH, Mejía-Rodríguez I, Alvarado I, Reyes-Morales H. Análisis del descenso de la mortalidad por cáncer cérvico-uterino en el IMSS, 1991-2005. Rev Med Inst Mex Seguro Soc 2006;44 (Supl 1):S129-S134.

  35. Instituto Nacional de Estadística y Geografía (INEGI). Registros administrativos. Estadísticas de mortalidad. n.d. [accessed october 12, 2015]. Available at: http://www.inegi.org.mx/est/contenidos/proyectos/registros/ vitales/mortalidad/presentacion.aspx (Retrieved October 12, 2015).

  36. Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer 2013. JAMA Oncol 2015 Appendix, eTable 10 pg 61-62, Published online May 28, 2015. doi:10.1001/jamaoncol.2015.0735.

  37. Aggarwal A, Unger-Saldaña K, Lewison G, Sullivan R. The challenge of cancer in middle-income countries with an ageing population: Mexico as a case study. Ecancermedicalscience 2015;9:536.

  38. Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, et al. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer 2008;123:421-429.

  39. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F. International Variation in Prostate Cancer Incidence and Mortality Rates. European Urology 2012;61(6):1079-1092.

  40. Gómez-Guerra LS, Martínez-Fierro ML, Alcántara-Aragón V, Ortiz- López R, Martínez-Villarreal RT, Morales-Rodríguez IB, et al. Population-based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases. BMC Cancer 2009;9:91.

  41. Ream E, Quennell A, Fincham L, Faithfull S, Khoo V, Wilson-Barnett J, Richardson A. Supportive care needs of men living with prostate cancer in England: a survey. Bri J Cancer 2008;98:1903-1909.

  42. Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, Knaul F, Mohar A, Finkelstein DM, Goss PE. Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol 2012;13:e335-e343.

  43. Sosa-Rubí SG, Walker D, Serván E. Práctica de mastografías y pruebas de Papanicolaou entre mujeres de áreas rurales de México. Salud Publica Mex 2009;51 supl 2:S236-S245.

  44. López Carrillo L, Suárez-López L, Torres-Sánchez L. Detección del cáncer de mama en México: síntesis de los resultados de la Encuesta Nacional de Salud Reproductiva. Salud Publica Mex 2009;51 supl 2:S345-S349.

  45. Anaya-Ruiz M, Vincent AK, Perez-Santos M. Cervical Cancer Trends in Mexico: Incidence, Mortality and Research Output. Asian Pac J Cancer Prev 2014;15(20):8689-8692.

  46. De la Vara-Salazar E, Suárez-López L, Ángeles-Llerenas A, Torres-Mejía G, Lazcano-Ponce E. Tendencias de la mortalidad por cáncer de mama en México, 1980-2009. Salud Publica Mex 2011;53:385-393.

  47. Dávila-Cervantes CA, Agudelo-Botero M. Average years of life lost due to breast and cervical cancer and the association with the marginalization index in Mexico in 2000 and 2010. Cad Saúde Pública 2014;30(5):1093-1102.

  48. Palacio-Mejía LS, Rangel-Gómez G, Hernández-Avila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: Mortality differences between urban and rural areas in Mexico. Salud Publica Mex 2003;45 (suppl 3):S315-S325.

  49. Agudelo M, Aguirre A, Dávila C. Variaciones en los años de vida perdidos por cánceres de mama y cérvico uterino en México según grado de marginación estatal, 1997 y 2007. Rev Chil Salud Pública 2010;14 (1):8-17.

  50. Palacio-Mejía LS, Lazcano-Ponce E, Allen-Leigh B, Hernández-Ávila M. Diferencias regionales en la mortalidad por cáncer de mama y cérvix en México entre 1979 y 2006. Salud Publica Mex 2009;51(supl 2):S208-S219.

  51. Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, Hernandez-Avila M. Decreasing Cervical Cancer Mortality in Mexico: Effect of a panicolaou Coverage, Birthrate, and the Importance of Diagnostic Validity of Cytology. Cancer Epidemiol Biomarkers Prev 2008;17(10):2808-2817.

  52. Lozano R, Knaul FM, Gómez-Dantés H, Arreola-Ornelas H, Méndez O. Tendencias en la mortalidad por cáncer de mama en México, 1979-2006. Observatorio de la Salud. In: Fundación Mexicana para la Salud. Documento de trabajo. Competitividad y Salud, Fundación Mexicana para la Salud. México: Funsalud, 2008.

  53. Venooka AP, Papandreoub C, Furusec J, Ladrón de Guevara L. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective. The Oncologist 2010;15 (Suppl 4):5-13.

  54. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, Oswaldo-Palma O, Kershenobich D, et al. Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud pública emergente? Salud Publica Mex 2007;49: suppl.3;S395-S-403.

  55. Fundación Mexicana para la Salud Hepática. La hepatitis C como un problema de salud pública en México. Salud Publica Mex 2011;53 supl 1:S61-S67.

  56. Ruíz-Godoy L, Rizo-Ríos F, Sánchez-Cervantes A, Osornio-Vargas C, García-Cuellar A, Meneses-García. Mortality due to lung cancer in Mexico. Lung Cancer 2007;58(2):184-190.

  57. Tovar-Guzmán VJ, López-Antuñano FJ, Rodríguez-Salgado N. Tendencias de la mortalidad por cáncer pulmonar en México, 1980–2000. Rev Panam Salud Publica 2005;17(4):254-262.

  58. Franco-Marina F, Villalba-Caloca J. La epidemia de cáncer pulmonar en México. Rev Inst Nal Enf Resp Mex 2001;14(4):207-214.

  59. Suwanrungruang K1, Sriplung H, Temiyasathit S, Waisri N, Daoprasert K, Kamsa-Ard S, et al. Appropriateness of the standard mortality/incidence ratio in evaluation of completeness of population-based cancer registry data. Asian Pac J Cancer Prev 2011;12(12):3283-3288.

  60. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods, II: completeness. Eur J Cancer 2009;45(5):756-764.

  61. Lozano R, Muradás MC. La baja mortalidad por cáncer en México: ilusión óptica o realidad. En: Avila JL, Hernández-Bringas HH, Narro-Robles J (coords). Cambio demográfico y desarrollo de México. Mexico City: Universidad Nacional Autónoma de México, 2014:49-74.




2020     |     www.medigraphic.com